+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brigatinib API Market - Global Forecast 2025-2030- Product Image
Brigatinib API Market - Global Forecast 2025-2030- Product Image
Sale

Brigatinib API Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6132457
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brigatinib API market is positioned for significant transformation, driven by advancements in precision oncology and dynamic regulatory policies. Strategic decisions in manufacturing, supply chain optimization, and partnership models will shape long-term value creation for industry stakeholders navigating this competitive landscape.

Market Snapshot: Brigatinib API Market Overview

The global Brigatinib API market, serving patients with ALK-positive non-small cell lung cancer, reflects robust activity as pharmaceutical companies invest in targeted therapeutics. Market momentum is anchored by technological breakthroughs, streamlined regulatory frameworks, and the rising demand for high-quality, consistent API supply. The projected market size and compound annual growth rate position this segment for sustained expansion as competition and innovation intensify.

Scope & Segmentation

This analysis provides comprehensive coverage of the Brigatinib API value chain, with deep-dives into production trends, distribution dynamics, and commercial strategies across regions and end users.

  • Distribution Channels: Hospital pharmacy, incorporating government hospitals and private hospitals; retail pharmacy, including chain pharmacies and independent pharmacies.
  • Line of Therapy: First-line and second-line and beyond therapeutic applications.
  • Dosage Strengths: 180 mg and 90 mg formulations tailored to patient and protocol needs.
  • End Users: Hospitals, such as academic and community hospitals, and specialty clinics focused on precision dosing and niche indications.
  • Regional Coverage: Extensive analysis across the Americas, Europe, Middle East & Africa, and Asia-Pacific, incorporating key sub-regions such as the United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan.
  • Technology Platforms: Continuous flow chemistry, process intensification, digital manufacturing intelligence, and advanced analytics supporting sustainable and scalable production.
  • Leading Companies: WuXi AppTec Co., Ltd., Lonza Group AG, Thermo Fisher Scientific Inc., Divi’s Laboratories Limited, Cambrex Corporation, Recipharm AB, Piramal Enterprises Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, and Jubilant Life Sciences Limited.

Key Takeaways: Strategic Insights on the Brigatinib API Market

  • Manufacturers are shifting to continuous and flow-based chemical synthesis for enhanced efficiency and minimal impurity levels, aligning with evolving industry best practices.
  • Regulatory reforms continue to streamline product approvals, encouraging early alignment and transparent quality control strategies throughout API development.
  • Strategic segmentation by distribution channel and therapy line enables precise production planning and inventory deployment to meet complex market demands.
  • Partnerships between pharmaceutical innovators and specialized contract manufacturers enable scalability, flexible capacity, and rapid response to regulatory change.
  • Robust supply chain strategies, including nearshoring and multi-sourcing, are increasingly prioritized to mitigate geopolitical and trade risks.
  • Digital tools and advanced analytics are central to quality assurance, predictive maintenance, and operational agility, reinforcing market differentiation.

United States Tariff Adjustments: Anticipated Impact

Impending changes to the United States tariff schedules in 2025 are expected to affect the Brigatinib API supply chain. Increased import duties on raw materials and intermediates sourced from Asia and Europe may elevate input costs and pressure margins. To manage these challenges, industry players are investing in nearshoring, collaborative regional synthesis centers, and proactive inventory management. Navigating tariff shifts will require agile cost frameworks and transparent communication with downstream stakeholders.

Methodology & Data Sources

This report integrates primary insights from senior industry stakeholders, including process scientists, supply chain leads, and regulatory experts, supported by secondary research from literature, patent databases, and technical white papers. Quantitative models and qualitative analyses were validated through independent expert peer review to ensure comprehensive and balanced outcomes.

Why This Report Matters

  • Uncovers actionable strategies for production optimization, cost management, and regulatory compliance within the Brigatinib API sector.
  • Highlights technology adoption, evolving partnership models, and market entry tactics across all major global regions.
  • Supports decision-makers in forecasting opportunities and managing potential supply chain and policy disruptions.

Conclusion

The Brigatinib API market offers substantial opportunities for agile, technology-driven companies adapting to regulatory shifts and supply chain complexity. Stakeholders prepared to leverage operational efficiency and strategic collaboration will be well positioned for sustainable growth and market leadership.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of green chemistry processes in brigatinib API synthesis to meet regulatory sustainability goals
5.2. Scale-up challenges and strategies in industrial production of high-purity brigatinib API for oncology markets
5.3. Integration of advanced purification technologies to minimize impurities in brigatinib active pharmaceutical ingredient
5.4. Impact of patent expiration timelines on generic brigatinib API manufacturing and market entry strategies
5.5. Collaborations between contract development and manufacturing organizations to optimize brigatinib API supply chains
5.6. Regulatory scrutiny on residual solvents driving adoption of novel solvent recovery techniques for brigatinib API
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brigatinib API Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.2.1. Government Hospitals
8.2.2. Private Hospitals
8.3. Retail Pharmacy
8.3.1. Chain Pharmacies
8.3.2. Independent Pharmacies
9. Brigatinib API Market, by Line Of Therapy
9.1. Introduction
9.2. First-Line
9.3. Second-Line And Beyond
10. Brigatinib API Market, by Dosage Strength
10.1. Introduction
10.2. 180 Mg
10.3. 90 Mg
11. Brigatinib API Market, by End User
11.1. Introduction
11.2. Hospitals
11.2.1. Academic Hospitals
11.2.2. Community Hospitals
11.3. Specialty Clinics
12. Americas Brigatinib API Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Brigatinib API Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Brigatinib API Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. WuXi AppTec Co., Ltd.
15.3.2. Lonza Group AG
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Divi’s Laboratories Limited
15.3.5. Cambrex Corporation
15.3.6. Recipharm AB
15.3.7. Piramal Enterprises Limited
15.3.8. Aurobindo Pharma Limited
15.3.9. Dr. Reddy’s Laboratories Limited
15.3.10. Jubilant Life Sciences Limited
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. BRIGATINIB API MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRIGATINIB API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRIGATINIB API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRIGATINIB API MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRIGATINIB API MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BRIGATINIB API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BRIGATINIB API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BRIGATINIB API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BRIGATINIB API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BRIGATINIB API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BRIGATINIB API MARKET: RESEARCHAI
FIGURE 24. BRIGATINIB API MARKET: RESEARCHSTATISTICS
FIGURE 25. BRIGATINIB API MARKET: RESEARCHCONTACTS
FIGURE 26. BRIGATINIB API MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRIGATINIB API MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRIGATINIB API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRIGATINIB API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRIGATINIB API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRIGATINIB API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRIGATINIB API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRIGATINIB API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRIGATINIB API MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRIGATINIB API MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRIGATINIB API MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRIGATINIB API MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRIGATINIB API MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRIGATINIB API MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRIGATINIB API MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRIGATINIB API MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRIGATINIB API MARKET SIZE, BY FIRST-LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRIGATINIB API MARKET SIZE, BY FIRST-LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRIGATINIB API MARKET SIZE, BY SECOND-LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRIGATINIB API MARKET SIZE, BY SECOND-LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRIGATINIB API MARKET SIZE, BY 180 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRIGATINIB API MARKET SIZE, BY 180 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRIGATINIB API MARKET SIZE, BY 90 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRIGATINIB API MARKET SIZE, BY 90 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRIGATINIB API MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRIGATINIB API MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRIGATINIB API MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRIGATINIB API MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRIGATINIB API MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRIGATINIB API MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BRIGATINIB API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BRIGATINIB API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BRIGATINIB API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BRIGATINIB API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. CANADA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. CANADA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. CANADA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. CANADA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. CANADA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. CANADA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 90. CANADA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 91. CANADA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. CANADA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. CANADA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. CANADA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. CANADA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. MEXICO BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. MEXICO BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. MEXICO BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 104. MEXICO BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRIGATINIB API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. GERMANY BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. GERMANY BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. GERMANY BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. GERMANY BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. GERMANY BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 176. GERMANY BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 177. GERMANY BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. GERMANY BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. FRANCE BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. FRANCE BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. FRANCE BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. FRANCE BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. FRANCE BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. FRANCE BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. FRANCE BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 190. FRANCE BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 191. FRANCE BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. FRANCE BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. ITALY BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ITALY BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ITALY BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. ITALY BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. ITALY BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. ITALY BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. ITALY BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 218. ITALY BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 219. ITALY BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. ITALY BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. ITALY BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ITALY BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. ITALY BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. ITALY BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. SPAIN BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. SPAIN BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. SPAIN BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. SPAIN BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. SPAIN BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. SPAIN BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. SPAIN BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 232. SPAIN BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 233. SPAIN BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 234. SPAIN BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. DENMARK BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. DENMARK BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. DENMARK BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. DENMARK BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. DENMARK BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. DENMARK BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. DENMARK BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 288. DENMARK BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 289. DENMARK BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. DENMARK BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. DENMARK BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. DENMARK BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. DENMARK BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 309. QATAR BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. QATAR BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. QATAR BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. QATAR BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. QATAR BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. QATAR BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. QATAR BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 316. QATAR BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 317. QATAR BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. QATAR BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. QATAR BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. QATAR BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. QATAR BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 322. QATAR BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 323. FINLAND BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. FINLAND BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. FINLAND BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. FINLAND BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. FINLAND BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. FINLAND BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. FINLAND BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 330. FINLAND BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 331. FINLAND BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. FINLAND BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. FINLAND BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. FINLAND BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. FINLAND BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 336. FINLAND BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 337. SWEDEN BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. SWEDEN BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. SWEDEN BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 340. SWEDEN BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 341. SWEDEN BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 342. SWEDEN BRIGATINIB API MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN BRIGATINIB API MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN BRIGATINIB API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN BRIGATINIB API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN BRIGATINIB API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN BRIGATINIB API MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 351. NIGERIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. NIGERIA BRIGATINIB API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. NIGERIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 354. NIGERIA BRIGATINIB API MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 355. NIGERIA BRIGATINIB API MARKET SIZE, BY RET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Brigatinib API Market report include:
  • WuXi AppTec Co., Ltd.
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Divi’s Laboratories Limited
  • Cambrex Corporation
  • Recipharm AB
  • Piramal Enterprises Limited
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Limited
  • Jubilant Life Sciences Limited

Related Reports

ALK Inhibitors Market - Global Forecast 2025-2030 - Product Image

ALK Inhibitors Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Vestibular Schwannoma - Pipeline Insight, 2025 - Product Image

Vestibular Schwannoma - Pipeline Insight, 2025

  • Clinical Trials
  • 50 Pages
  • Global
From
Neurofibromatosis Type 2 - Pipeline Insight, 2025 - Product Image

Neurofibromatosis Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Crizotinib Drugs Market - Global Forecast 2025-2030 - Product Image

Crizotinib Drugs Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.